Countstar


Shanghai explores stem cell transplantation for curing Parkinson's disease

With the rapid development of population aging, how to resolve the burden of family and society caused by Parkinson's disease has become a major practical issue in the medical community. Progress has been made in the clinical treatment of Parkinson's disease with stem cell transplantation in a hospital in Shanghai.

Parkinson's disease is a degenerative disease of nervous system cells. The lesions are located in the globus pallidum and putamen nuclei. The age of onset is more than 60 years old. Symptoms include slow movement, body stiffness, tremors and shaking of limbs.

At present, there are more than 5 million Parkinson's disease patients in China. Among existing treatments, drugs have limited effectiveness; Surgery often uses stereotactic techniques to damage the thalamus or globus pallidus, or can be life-threatening or cause new disabilities.

It is known that the relevant field experts at home and abroad have used fetal brain transplantation to treat this disease, but this method because of fetal brain donor source is difficult, at the same time need to carry out craniotomy surgery, there are strong immune rejection, low survival rate, not lasting and other defects.

In this context, stem cell transplantation for the treatment of Parkinson's disease has become a new option and approach. According to a professor at the hospital, stem cells are primitive cells in the human body, which have the advantages of self-replication and no blood type difference or rejection, and have gradually become an important treatment for cellular diseases in recent years.

According to the report, stem cell transplantation for Parkinson's disease is to introduce a certain number of stem cells into the diseased brain tissue by means of intracranial puncture, lumbar puncture, vein and artery. The professor says the treatment is already working in some patients.
Related News